Does Dr. RICHARD ADKINS have financial conflicts of interest?

Dr. RICHARD ADKINS (M.D.) has received a total of $1,780 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,780 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. RICHARD ADKINS?

According to CMS Open Payments data, Dr. RICHARD ADKINS received funding from VERTOS MEDICAL ($319), BOSTON SCIENTIFIC CORPORATION ($254), and SCILEX PHARMACEUTICALS ($242).

Does Dr. RICHARD ADKINS receive research grants or speaking fees?

Dr. RICHARD ADKINS has received $1,780 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. RICHARD ADKINS

M.D.Real-Time Hydrated

Specialty: Pain Medicine, Interventional Pain Medicine

Practice Location: MELBOURNE, FL 32901

NPI Number: 1700887775

LIFETIME INDUSTRY VALUE

$1,780

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ADKINS is a verified Pain Medicine, Interventional Pain Medicine practitioner based in MELBOURNE, FL.

Between 2021 and 2025, Dr. ADKINS had an overall industry promotional and research financial footprint of $1,780 as recorded in the federal CMS Open Payments database.

$1,780 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ADKINS's primary funding source is VERTOS MEDICAL, which accounts for $319 (representing 17.9% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

VERTOS MEDICAL

Rank 1

$319

17.9%

BOSTON SCIENTIFIC CORPORATION

Rank 2

$254

14.2%

SCILEX PHARMACEUTICALS

Rank 3

$242

13.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.